14.7
Medical Imaging and Diagnostics
Chapter contents: Chapter 14: Nuclear and Particle Physics
Most medical and related applications of nuclear physics are driven, at their core, by the difference between a radioactive substance and a non-radioactive substance. One of the first such methods is the precision measurement and detection method known as radioimmunoassay (RIA). Developed by Rosalyn Sussman Yalow and Solomon Berson in the late 1950s, RIA relies on the principle of competitive binding. For the particular substance being measured, a radioactively labeled sample is prepared and mixed with the unlabeled substance being measured. A known quantity of antibodies is then introduced. By measuring the radioactivity in the bound or unbound fraction after the reaction, technicians can detect and measure the precise amount of the target substance. Radioimmunoassay is essential in cancer screening, hepatitis diagnosis, narcotics investigation, and other analyses.
A host of medical imaging techniques employ nuclear radiation. What makes nuclear radiation so useful? First, radiation can easily penetrate tissue; hence, it is a useful probe to monitor conditions inside the body. Second, nuclear radiation depends on the nuclide and not on the chemical compound it is in, so that a radioactive nuclide can be put into a compound designed for specific purposes. The compound is said to be tagged. A tagged compound used for medical purposes is called a radiopharmaceutical. Radiation detectors external to the body can determine the location and concentration of a radiopharmaceutical to yield medically useful information. For example, certain drugs are concentrated in inflamed regions of the body, and this information can aid diagnosis and treatment as seen in Figure 14.7.1. Another application utilizes a radiopharmaceutical which the body sends to bone cells, particularly those that are most active, to detect cancerous tumors or healing points. Images can then be produced of such bone scans. Radioisotopes are also used to determine the functioning of body organs, such as blood flow, heart muscle activity, and iodine uptake in the thyroid gland.
Medical Application
Table 14.7.1 lists selected medical diagnostic uses of radiopharmaceuticals, including named preparations and adult activity ranges from their product labels. Many organs can be imaged with a variety of nuclear isotopes replacing a stable element by a radioactive isotope. One common diagnostic employs radioactive iodine to image the thyroid, since iodine is concentrated in that organ. Thyroid tissue that concentrates more radioactive iodine emits more radiation. A gamma camera detects this radiation to form an image showing how the iodine is distributed within the thyroid. Note that there is more than one isotope that can be used for several types of scans. Another common nuclear diagnostic is the thallium scan for the cardiovascular system, particularly used to evaluate blockages in the coronary arteries and examine heart activity. The salt TlCl can be used, because thallium is taken up by viable heart muscle cells in a manner similar to potassium. Gallium-67 accumulates where there is rapid cell growth, such as in tumors and sites of infection. Hence, it is useful in cancer imaging. Usually, the patient receives the injection one day and has a whole body scan 3 or 4 days later because it can take several days for the gallium to build up.
| Diagnostic use | Radiopharmaceutical | Adult activity (MBq) | Adult activity (mCi) |
|---|---|---|---|
| Bone imaging | Tc-99m medronate (MDP) | 370–740 | 10–20 |
| Lung perfusion | Tc-99m aggregated albumin (MAA) | 37–148 | 1–4 |
| Brain perfusion | Tc-99m exametazime (CERETEC) | 555–1110 | 15–30 |
| Thyroid uptake and imaging | Sodium iodide I-123 | 3.7–14.8 | 0.1–0.4 |
| PET imaging of glucose metabolism | Fludeoxyglucose F-18 (FDG) | 185–370 | 5–10 |
Note that Table 14.7.1 lists several diagnostic uses for , where “m” stands for a metastable state of the technetium nucleus. Perhaps 80 percent of all radiopharmaceutical procedures employ because of its many advantages. One is that the decay of its metastable state produces a single, easily identified 0.141-MeV
ray. Additionally, the radiation dose to the patient is limited by the short 6.0-h half-life of
. On site, technetium-99m is commonly obtained from a generator containing molybdenum-99, which decays to technetium-99m. Technetium-99m can be attached to many compounds to allow the imaging of the skeleton, heart, lungs, kidneys, etc.
Figure 14.7.2 shows one of the simpler methods of imaging the concentration of nuclear activity, employing a device called an Anger camera or gamma camera. A piece of lead with holes bored through it collimates rays emerging from the patient, allowing detectors to receive rays from specific directions only. The computer analysis of detector signals produces an image. One of the disadvantages of this detection method is that there is no depth information (i.e., it provides a two-dimensional view of the tumor as opposed to a three-dimensional view), because radiation from any location under that detector produces a signal.
Imaging techniques much like those in x-ray computed tomography (CT) scans use nuclear activity in patients to form three-dimensional images. Figure 14.7.3 shows a patient in a circular array of detectors that may be stationary or rotated, with detector output used by a computer to construct a detailed image. This technique is called single-photon-emission computed tomography (SPECT) or sometimes simply SPET. The spatial resolution of this technique is poor, about 1 cm, but the contrast (i.e. the difference in visual properties that makes an object distinguishable from other objects and the background) is good.
Images produced by
emitters have become important in recent years. When the emitted positron () encounters an electron, mutual annihilation occurs, producing two rays. These rays have identical 0.511-MeV energies (the energy comes from the conversion of the electron’s and positron’s rest energy into photon energy) and they move directly away from one another, allowing detectors to determine their point of origin accurately, as shown in Figure 14.7.4. The system is called positron emission tomography (PET). It requires detectors on opposite sides to simultaneously (i.e., at the same time) detect photons of 0.511-MeV energy and utilizes computer imaging techniques similar to those in SPECT and CT scans. Examples of
-emitting isotopes used in PET are
,
,
, and
. This list includes C, N, and O, and so they have the advantage of being able to function as tags for natural body compounds. Its resolution of 0.5 cm is better than that of SPECT; the accuracy and sensitivity of PET scans make them useful for examining the brain’s anatomy and function. The brain’s use of oxygen and water can be monitored with
. PET is used extensively for diagnosing brain disorders. It can note decreased metabolism in certain regions prior to a confirmation of Alzheimer’s disease. PET can locate regions in the brain that become active when a person carries out specific activities, such as speaking, closing their eyes, and so on.